781 results on '"Horsmans, Y."'
Search Results
2. Risk of hepatocellular carcinoma and fibrosis evolution in hepatitis C patients with severe fibrosis or cirrhosis treated with direct acting antiviral agents
3. Place de la biopsie hépatique en présence d’une maladie hépatique chronique chez l’adulte
4. Oligofructose promotes satiety in healthy human: a pilot study
5. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study
6. Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats
7. Safety and efficacy of twice daily versus every 8 hour Telaprevir with peginterferon/ribavirin (PR) in patients with cirrhosis
8. OPTIMIZE trial: Non-inferiority of twice-daily telaprevir versus administration every 8 hours in treatment-naïve, genotype 1 HCV infected patients
9. The surgical management of congenital liver cysts: The need for a tailored approach with appropriate patient selection and proper surgical technique
10. Effect of hepatic insufficiency on pharmacokinetics and drug dosing
11. Effect of enteral versus parenteral feeding on hepatic blood flow and steady state propofol pharmacokinetics in ICU patients
12. Clinical trial: a randomized trial of pegylated-interferon-α-2a plus ribavirin with or without amantadine in treatment-naïve or relapsing chronic hepatitis C patients
13. Foetal ‘flat’ bile acids reappear during human liver regeneration after surgery
14. A health economic model to assess the cost-effectiveness of PEG IFN α-2a and ribavirin in patients with mild chronic hepatitis C
15. Eosinophilic gastroenteritis presenting with colitis and cholangitis
16. Interferon-induced depression in chronic hepatitis C
17. Hypervitaminosis A-induced liver fibrosis: stellate cell activation and daily dose consumption
18. LATE SURVIVAL AFTER SURGICAL RESECTION of PRIMARY LIVER MALIGNANCIES IS LINKED TO UNDERLYING CHRONIC LIVER DISEASE: 8
19. PERCUTANEOUS and SURGICAL RADIOFREQUENCY ABLATION (RFA) for LIVER MALIGNANCIES: A DIFFERENT PHILOSOPHY of TREATMENT?: 11
20. Molecular events associated with accelerated proliferative response in rat livers when partial hepatectomy is preceded by a sham operation
21. Ombitasvir/paritaprevir/ritonavir plus ribavirin for 24 weeks in patients with HCV GT4 and compensated cirrhosis (AGATE-I Part II)
22. Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trial
23. Interaction between azathioprine and aminosalicylates: an in vivo study in patients with Crohn’s disease
24. After portal branch ligation in the rat, cellular proliferation in associated with selective induction of c-Ha-ras, p53, cyclin E, and Cdk2
25. Liver abscesses due to Fusobacterium species
26. Relationship between red cell mean corpuscular volume and 6-thioguanine nucleotides in patients treated with azathioprine
27. EARLY DOWN-REGULATION OF CYTOCHROME P 450 3A AND 2E1 IN THE REGENERATING RAT LIVER IS NOT RELATED TO THE LOSS OF LIVER MASS
28. p53, c-Ha-ras AND IL-1β AFTER SURGICAL PROCEDURES NOT INDUCING HEPATOCYTES PROLIFERATION
29. Immunisation after hepatitis B polyvalent vaccination among children in South Kivu Province, Democratic Republic of the Congo
30. Mucin-producing hepatic cystic neoplasms: an uncommon but challenging disease often misdiagnosed and mismanaged
31. Paracetamol-induced liver toxicity after intravenous administration
32. AMOXYCILLIN-CLAVULANATE-INDUCED HEPATITIS IS LINKED TO THE DRB1*1501-DRB5*0101-DQB1*0602 HAPLOTYPE BUT NOT TO DPB ANTIGENS
33. Acute lobular hepatitis as the first manifestation of recurrent autoimmune hepatitis after orthotopic liver transplantation
34. Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy
35. C10/13 COMPARISON BETWEEN FORMALIN AND BOUIN'S SOLUTION FIXATIONS FOR HBc ANTIGEN IMMUNODETECTION IN CHRONIC HEPATITIS B.
36. Pruritus Associated with Cholestatic Liver Disease
37. Fenoterol-induced hepatitis in a pregnant woman: A case report
38. Relationship between Mephenytoin, Phenytoin and Tolbutamide Hydroxylations in Healthy African Subjects
39. Symptomatic myopathy in hepatitis C infection without interferon therapy
40. Transient blurred vision after interferon for chronic hepatitis C
41. Cryopreservation of rat precision-cut liver slices by ultrarapid freezing: Influence on phase I and II metabolism and on cell viability upon incubation for 24 hours
42. Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort
43. Mucin-producing hepatic cystic neoplasms: an uncommon but challenging disease often misdiagnosed and mismanaged.
44. A43 Molecular epidemiology of hepatitis B virus in South Kivu, an eastern province of the Democratic Republic of Congo
45. Nouvelles possibilités thérapeutiques contre l'hépatite B
46. Hypogammaglobulinemia, a new risk factor for hepatitis B virus reactivation: about two cases.
47. Different adjuvants induce common innate pathways that are associated with enhanced adaptive responses against a model antigen in humans
48. Pharmacokinetic interactions between simeprevir and ledipasvir in treatment-naive hepatitis C virus genotype 1-infected patients without cirrhosis treated with a simeprevir-sofosbuvir-ledipasvir regimen
49. Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection
50. Response by Drs. Horsmans, Geubel, and Pauwels
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.